who should not use tirzepatide In adults with obesity but diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Mounjaro - Newgate Medical Group

Our team, led by experienced professionals like Irina Manukyan, FNP-C, is dedicated to providing customized treatments that enhance your natural beauty

PMCID: PMC8628984

Tirzepatide produces approximately 20-22% body weight reduction at its highest approved dose of 15mg weekly, which is closer to retatrutide performance than semaglutide is

Testosterone: The gradual decline of testosterone (yes, women have it too!) can cause a loss of lean muscle mass

Every stage from finishing clinical trials to getting the drug on the market influences when itll actually become available to patients

Quality Assurance & Stability